Author

Xiaotong Zhao

Cleveland State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Bin Su· 1 shared Khalid Sossey‐AlaouiiD· 1 shared Kristen Weber Bonk· 1 shared Ruth A. KeriiD· 1 shared Wei Wang· 1 shared Yeaji KimiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bin Su

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The small molecule inhibitor SU056-mediated targeting of YB1 inhibits the Rb pathway in triple-negative breast cancer tumors

Wei Wang, Yeaji Kim, Xiaotong Zhao, Kristen Weber Bonk, Ruth A. Keri, Bin Su, Khalid Sossey‐Alaoui

This study shows that SU056, a YB1 inhibitor, suppresses TNBC growth and metastasis by targeting the Rb pathway, with enhanced efficacy when combined with CDK4/6 inhibition.

bioRxiv · Sep 10, 2026 · PreprintCancer Biology